Bertha Maria Verdel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bertha Maria Verdel has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Patrick Cyriel Souverein
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht The Netherlands
4 shared publications - Toine Cornelus Gerardus Egberts
Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands
2 shared publications A.C.G. Egberts
Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands
1 shared publicationAntoine C. G. Egberts
Utrecht Institute for Pharmaceutical Sciences
1 shared publication- Claudia Dantuma-Wering
Department of PharmacoTherapy, -Epidemiology and -Economics, Groningen Institute of Pharmacy, School of Science and Engineering, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
1 shared publication - Denise L. Hope
School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD 4222, Australia
1 shared publication
Latest Publications
- Open Access
The International Pharmacy Game: A Comparison of Implementation in Seven Universities World-Wide
The utilization of serious games and simulations in health professional education has increased. The Pharmacy Game is one such concept that intersects gamification and simulation, in which pharmacy student teams competitively manage simulated pharmacies; a concept included in the pharmacy curricula of seven international universities. This study aimed to compare the implementation and conduct of the Pharmacy Game of participant universities and their students’ performance in the same educational task. Data were collected via a questionnaire completed by academic staff in April 2020, and the collation of results of the same patient case was conducted at each university (April 2020 to March 2021). The main results reflected differences in the game frequencies and the curricular approach (standalone or integrated course) and in the learning outcomes for the Pharmacy Game. Other differences were identified in the extent to which students of other professions were part of the game such as medical students or pharmacy assistants. Student case outcomes revealed similar strengths across the universities in patient communication and focus on safety, with variations identified as areas for improvement. Collation of the international utilization of the Pharmacy Game identified a broad spectrum of similar learning outcomes, inspiring a model of international core and aspirational learning outcomes. While the Pharmacy Game has been implemented with flexibility regarding the numbers of teams (4–10) and the duration of activity (12–36 days), all universities reported positive experiences and student outcomes, suggesting that the intervention represents a potential tool to deliver capstone learning experiences, promote interprofessional education, reinforce patient safety, and prepare pharmacy graduates for future practice.
Open AccessThe International Pharmacy Game: A Comparison of Implementation in Seven Universities World-Wide
The utilization of serious games and simulations in health professional education has increased. The Pharmacy Game is one such concept that intersects gamification and simulation, in which pharmacy student teams competitively manage simulated pharmacies; a concept included in the pharmacy curricula of seven international universities. This study aimed to compare the implementation and conduct of the Pharmacy Game of participant universities and their students’ performance in the same educational task. Data were collected via a questionnaire completed by academic staff in April 2020, and the collation of results of the same patient case was conducted at each university (April 2020 to March 2021). The main results reflected differences in the game frequencies and the curricular approach (standalone or integrated course) and in the learning outcomes for the Pharmacy Game. Other differences were identified in the extent to which students of other professions were part of the game such as medical students or pharmacy assistants. Student case outcomes revealed similar strengths across the universities in patient communication and focus on safety, with variations identified as areas for improvement. Collation of the international utilization of the Pharmacy Game identified a broad spectrum of similar learning outcomes, inspiring a model of international core and aspirational learning outcomes. While the Pharmacy Game has been implemented with flexibility regarding the numbers of teams (4–10) and the duration of activity (12–36 days), all universities reported positive experiences and student outcomes, suggesting that the intervention represents a potential tool to deliver capstone learning experiences, promote interprofessional education, reinforce patient safety, and prepare pharmacy graduates for future practice.
- 24 November 2010
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 89 (1) , 89-96
Use of Serotonergic Drugs and the Risk of Bleeding
We assessed several classes of serotonergic drugs in order to evaluate whether they constitute a risk factor for hospitalization for bleeding (gastrointestinal, intracranial, or in the female genital...
- 24 November 2010
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 89 (1) , 89-96
Use of Serotonergic Drugs and the Risk of Bleeding
We assessed several classes of serotonergic drugs in order to evaluate whether they constitute a risk factor for hospitalization for bleeding (gastrointestinal, intracranial, or in the female genital...
- 5 May 2009
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 18 (7) , 602-609
Risk of drug‐induced photosensitivity: focus on spectroscopic and molecular characteristics
Background: Drug‐induced photosensitivity is difficult to predict and remains a challenge for both the dermatological clinical practice and pharmacovigilance.Purpose: To assess the association between spectroscopic and molecular characteristics and the occurrence of photosensitivity reactions.Methods: For 143 well‐known photosensitisers (e.g. tetracyclines, diuretics), we retrieved information on spectroscopic and molecular parameters, including: absorption maximumλmax, molar absorption coefficientε, area under the absorption curve (AUC), molecular weight and configuration, hetero and aromatic halogen atoms, lipophilicity (log P) and acid/base status (pKa). In the WHO‐ADR database, all reports with suspected adverse drug reactions of the study drugs were selected. We identified all reports on photosensitivity reactions and defined them as cases. All other reports were selected as non‐cases. A case–non‐case approach was performed to assess the spectroscopic and molecular exposure variables as a factor for photosensitivity reactions. Logistic regression was used to calculate odds ratios (OR) with 95% confidence intervals (CI).Results: Aλmaxbetween 290 and 320 nm (OR 3.74, 95% CI 3.45–4.06), and anε > 20 000 M−1 cm−1(OR 5.49, 95% CI 5.10–5.92) were highly associated with the reporting of photosensitivity reactions. Risk of the photosensitivity reactions was significantly increased among intermediate or high AUCs compared to low AUC. Low molecular weight and aromatic halogen atoms were associated with photosensitivity reactions (OR 2.37, 95% CI 2.07–2.71 resp. OR 3.37, 95% CI 3.15–3.61) as were logp < 1 and pKa < 7.Conclusion: The reporting of photosensitivity reactions to established phototoxic drug classes is strongly influenced by spectroscopic and physicochemical characteristics of individual drugs. Copyright © 2009 John Wiley & Sons, Ltd.
- 5 May 2009
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 18 (7) , 602-609
Risk of drug‐induced photosensitivity: focus on spectroscopic and molecular characteristics
Background: Drug‐induced photosensitivity is difficult to predict and remains a challenge for both the dermatological clinical practice and pharmacovigilance.Purpose: To assess the association between spectroscopic and molecular characteristics and the occurrence of photosensitivity reactions.Methods: For 143 well‐known photosensitisers (e.g. tetracyclines, diuretics), we retrieved information on spectroscopic and molecular parameters, including: absorption maximumλmax, molar absorption coefficientε, area under the absorption curve (AUC), molecular weight and configuration, hetero and aromatic halogen atoms, lipophilicity (log P) and acid/base status (pKa). In the WHO‐ADR database, all reports with suspected adverse drug reactions of the study drugs were selected. We identified all reports on photosensitivity reactions and defined them as cases. All other reports were selected as non‐cases. A case–non‐case approach was performed to assess the spectroscopic and molecular exposure variables as a factor for photosensitivity reactions. Logistic regression was used to calculate odds ratios (OR) with 95% confidence intervals (CI).Results: Aλmaxbetween 290 and 320 nm (OR 3.74, 95% CI 3.45–4.06), and anε > 20 000 M−1 cm−1(OR 5.49, 95% CI 5.10–5.92) were highly associated with the reporting of photosensitivity reactions. Risk of the photosensitivity reactions was significantly increased among intermediate or high AUCs compared to low AUC. Low molecular weight and aromatic halogen atoms were associated with photosensitivity reactions (OR 2.37, 95% CI 2.07–2.71 resp. OR 3.37, 95% CI 3.15–3.61) as were logp < 1 and pKa < 7.Conclusion: The reporting of photosensitivity reactions to established phototoxic drug classes is strongly influenced by spectroscopic and physicochemical characteristics of individual drugs. Copyright © 2009 John Wiley & Sons, Ltd.
- 1 January 2008
- Published by Springer Nature in Drug Safety
- Vol. 31 (10) , 877-884
Drug-Related Nephrotoxic and Ototoxic Reactions
Background: Drug-induced ototoxicity is a subject of interest because many diseases are treated with drugs that have potential toxic effects on the ear. There is evidence that both inner ear and kidney tissue are immunologically, biochemically and functionally related. It has been suggested that drugs that influence the transport of sodium and/or potassium change ionic homeostasis in the inner ear and, hence, induce functional disturbances such as hearing loss, tinnitus and vertigo. Objectives: To assess whether renal suspected adverse drug reactions (sADRs) have predictive value for ear and labyrinth adverse drug reactions (ADRs) and whether drug classes involved have influence ion transport systems. Study design: Data were obtained from the Netherlands Pharmacovigilance Centre Lareb. The study base comprised all reports of sADRs up until 1 January 2007. Cases were all sADRs for relevant renal disorders and all sADRs for relevant ear disorders. All other reported sADRs were selected as ’non-cases’. The relationship between drug classes and renal, ear and labyrinth sADRs was evaluated by calculating reporting odds ratios (RORs). An ROR >1.50 was regarded as a cut-off value for an association. Drug classes were classified into four groups: (A) ROR kidney 1.50 and ROR ear 1.50 and ROR ear >1.50. For each group, we calculated odds ratios (ORs) for the association between the group classification and the effect on ion channels/ ion transport systems in kidney and ear tissues. Results: Of 193 drug classes with relevant ADRs for renal disorders, 120 drug classes also had reports on ototoxic reactions. Fourteen out of 120 drug classes had an ROR >1.50 for the association between the drug class and both renal and ear sADRs. Among these drug classes were several with a well known ability to induce renal (adverse) effects and ear and labyrinth disorders, such as loop diuretics, aminoglycosides and quinine. We found that one mechanistic commonality of the drug classes mentioned in the reports was the ability to affect ion transport systems. The percentage of drugs having this property differed between the four groups. The ORs for groups D and B were significantly higher compared with the reference group (OR 12.2, 95% CI 3.0, 30.5 and OR 8.7, 95% CI 2.4, 18.7, respectively), whereas there was no association for group C. Conclusion: Our data suggest that renal sADRs as such are not a marker for druginduced ear and labyrinth disorders. However, the ability of drugs to act on ion channels or ion transport systems and, therefore, have an influence on ionic homeostasis in the kidney and ear might be a predictor for the possible occurrence of drug-related ototoxicity.
- 1 January 2008
- Published by Springer Nature in Drug Safety
- Vol. 31 (10) , 877-884
Drug-Related Nephrotoxic and Ototoxic Reactions
Background: Drug-induced ototoxicity is a subject of interest because many diseases are treated with drugs that have potential toxic effects on the ear. There is evidence that both inner ear and kidney tissue are immunologically, biochemically and functionally related. It has been suggested that drugs that influence the transport of sodium and/or potassium change ionic homeostasis in the inner ear and, hence, induce functional disturbances such as hearing loss, tinnitus and vertigo. Objectives: To assess whether renal suspected adverse drug reactions (sADRs) have predictive value for ear and labyrinth adverse drug reactions (ADRs) and whether drug classes involved have influence ion transport systems. Study design: Data were obtained from the Netherlands Pharmacovigilance Centre Lareb. The study base comprised all reports of sADRs up until 1 January 2007. Cases were all sADRs for relevant renal disorders and all sADRs for relevant ear disorders. All other reported sADRs were selected as ’non-cases’. The relationship between drug classes and renal, ear and labyrinth sADRs was evaluated by calculating reporting odds ratios (RORs). An ROR >1.50 was regarded as a cut-off value for an association. Drug classes were classified into four groups: (A) ROR kidney 1.50 and ROR ear 1.50 and ROR ear >1.50. For each group, we calculated odds ratios (ORs) for the association between the group classification and the effect on ion channels/ ion transport systems in kidney and ear tissues. Results: Of 193 drug classes with relevant ADRs for renal disorders, 120 drug classes also had reports on ototoxic reactions. Fourteen out of 120 drug classes had an ROR >1.50 for the association between the drug class and both renal and ear sADRs. Among these drug classes were several with a well known ability to induce renal (adverse) effects and ear and labyrinth disorders, such as loop diuretics, aminoglycosides and quinine. We found that one mechanistic commonality of the drug classes mentioned in the reports was the ability to affect ion transport systems. The percentage of drugs having this property differed between the four groups. The ORs for groups D and B were significantly higher compared with the reference group (OR 12.2, 95% CI 3.0, 30.5 and OR 8.7, 95% CI 2.4, 18.7, respectively), whereas there was no association for group C. Conclusion: Our data suggest that renal sADRs as such are not a marker for druginduced ear and labyrinth disorders. However, the ability of drugs to act on ion channels or ion transport systems and, therefore, have an influence on ionic homeostasis in the kidney and ear might be a predictor for the possible occurrence of drug-related ototoxicity.